Literature DB >> 17719541

Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.

Sanjeev Das1, Lakshmi Raj, Bo Zhao, Yuki Kimura, Alan Bernstein, Stuart A Aaronson, Sam W Lee.   

Abstract

A critical unresolved issue about the genotoxic stress response is how the resulting activation of the p53 tumor suppressor can lead either to cell-cycle arrest and DNA repair or to apoptosis. We show here that hematopoietic zinc finger (Hzf), a zinc-finger-containing p53 target gene, modulates p53 transactivation functions in an autoregulatory feedback loop. Hzf is induced by p53 and binds to its DNA-binding domain, resulting in preferential transactivation of proarrest p53 target genes over its proapoptotic target genes. Thus, p53 activation results in cell-cycle arrest in Hzf wild-type MEFs, while in Hzf(-/-) MEFs, apoptosis is induced. Exposure of Hzf null mice to ionizing radiation resulted in enhanced apoptosis in several organs, as compared to in wild-type mice. These findings provide novel insights into the regulation of p53 transactivation function and suggest that Hzf functions as a key player in regulating cell fate decisions in response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719541      PMCID: PMC2779720          DOI: 10.1016/j.cell.2007.06.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  47 in total

1.  Gene trapping of two novel genes, Hzf and Hhl, expressed in hematopoietic cells.

Authors:  M Hidaka; G Caruana; W L Stanford; M Sam; P H Correll; A Bernstein
Journal:  Mech Dev       Date:  2000-01       Impact factor: 1.882

2.  SUMO-1 modification activates the transcriptional response of p53.

Authors:  M S Rodriguez; J M Desterro; S Lain; C A Midgley; D P Lane; R T Hay
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

3.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

4.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

5.  Role of BAX in the apoptotic response to anticancer agents.

Authors:  L Zhang; J Yu; B H Park; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

6.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

Review 7.  The complexity of p53 stabilization and activation.

Authors:  M F Lavin; N Gueven
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

8.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

Authors:  R Khosravi; R Maya; T Gottlieb; M Oren; Y Shiloh; D Shkedy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

9.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.

Authors:  L D Attardi; E E Reczek; C Cosmas; E G Demicco; M E McCurrach; S W Lowe; T Jacks
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

10.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

View more
  78 in total

1.  Regulation of the DNA damage response by p53 cofactors.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

2.  Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1.

Authors:  Yingjuan Qian; Yong-Sam Jung; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-21       Impact factor: 11.205

3.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

4.  p53-mediated apoptosis requires inositol hexakisphosphate kinase-2.

Authors:  Michael A Koldobskiy; Anutosh Chakraborty; J Kent Werner; Adele M Snowman; Krishna R Juluri; M Scott Vandiver; Seyun Kim; Shira Heletz; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 5.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

Review 6.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

Review 7.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

Review 8.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.

Authors:  Xinyue Zhang; Yunlong He; Kyoung-Hwa Lee; Wendy Dubois; Ziqing Li; Xiaolin Wu; Alexander Kovalchuk; Weimin Zhang; Jing Huang
Journal:  Cell Cycle       Date:  2013-03-27       Impact factor: 4.534

10.  AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.

Authors:  Katja Höpker; Henning Hagmann; Safiya Khurshid; Shuhua Chen; Pia Hasskamp; Tamina Seeger-Nukpezah; Katharina Schilberg; Lukas Heukamp; Tobias Lamkemeyer; Martin L Sos; Roman K Thomas; Drew Lowery; Frederik Roels; Matthias Fischer; Max C Liebau; Ulrike Resch; Tülay Kisner; Fabian Röther; Malte P Bartram; Roman Ulrich Müller; Francesca Fabretti; Peter Kurschat; Björn Schumacher; Matthias Gaestel; René H Medema; Michael B Yaffe; Bernhard Schermer; H Christian Reinhardt; Thomas Benzing
Journal:  EMBO J       Date:  2012-08-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.